What are the HRS/EHRA guidelines for genetic testing in long QT syndrome (LQTS)?

Updated: Nov 29, 2017
  • Author: Ali A Sovari, MD, FACP, FACC; Chief Editor: Mikhael F El-Chami, MD  more...
  • Print
Answer

In 2011, the HRS and EHRA issued a joint expert consensus statement on genetic testing for channelopathies and cardiomyopathies with the following recommendations for LQTS testing [38] :

Comprehensive or LQT1-3 (KCNQ1, KCNH2, and SCN5A)–targeted LQTS genetic testing for:

  • Individuals with a strong clinical index of suspicion for LQTS based on their clinical history, family history, and expressed ECG phenotype (Class I)
  • Asymptomatic individuals with idiopathic QT prolongation on serial 12-lead ECGs defined as QTc longer than 480 ms (prepuberty) or longer than 500 ms (adults) (Class I); may be considered for QTc values above 460 ms (prepuberty) or over 480 ms (adults) (Class IIb)

In addition, mutation-specific genetic testing is recommened for family members following identification of LQTS mutation in an index case. (Class I)


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!